[Form 4] RB GLOBAL INC. Insider Trading Activity
Rhea-AI Filing Summary
Michael Thomas Steven Lewis, Chief Operations Officer of RB Global, Inc. (RBA), reported acquisitions on 09/18/2025 of dividend equivalent rights tied to restricted share unit (RSU) grants. Nineteen dividend equivalent rights accrued for the 2024 RSU grant and eleven dividend equivalent rights accrued for the 2025 RSU grant; each right represents a contingent entitlement to the economic equivalent of one RBA common share and vests proportionately with the underlying RSUs. Following these reported transactions the filing shows 84 and 23 dividend-equivalent positions, respectively, held in a direct ownership form. The transactions were signed by an attorney-in-fact on 09/22/2025.
Positive
- Equity alignment: Dividend equivalent rights tie executive economic interests to common shares via RSU vesting.
- Routine, compliant disclosure: Form 4 reports the transactions and includes an attorney-in-fact signature, indicating procedural compliance.
Negative
- None.
Insights
TL;DR: Routine equity-based compensation accruals, modest share-equivalent increases for a company officer.
The Form 4 discloses non-cash accruals of dividend equivalent rights tied to RSUs rather than open-market purchases or sales. These entries increase the reporting officer's economic exposure to the issuer through award accruals of 19 and 11 share equivalents, bringing reported direct holdings to 84 and 23 in the respective award series. For investors, this is a routine compensation disclosure without cash proceeds or disposition events; it signals continued alignment of the officer with shareholder outcomes through RSU-linked entitlements.
TL;DR: Compliance filing documents executive compensation-related accruals; standard disclosure under Section 16.
The disclosure is consistent with required Section 16 reporting for officers receiving equity-linked awards. It details dividend equivalent rights that vest with the underlying RSUs and confirms direct beneficial ownership form. The filing includes an attorney-in-fact signature, indicating proper execution. There are no indications of option exercises, sales, or other governance concerns in this filing.